GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Cyclically Adjusted FCF per Share

Mega Lifesciences PCL (BKK:MEGA-R) Cyclically Adjusted FCF per Share : ฿1.80 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Mega Lifesciences PCL's adjusted free cash flow per share for the three months ended in Mar. 2025 was ฿0.147. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ฿1.80 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Mega Lifesciences PCL's average Cyclically Adjusted FCF Growth Rate was 12.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Mega Lifesciences PCL was 16.30% per year. The lowest was 16.30% per year. And the median was 16.30% per year.

As of today (2025-07-17), Mega Lifesciences PCL's current stock price is ฿27.08483. Mega Lifesciences PCL's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ฿1.80. Mega Lifesciences PCL's Cyclically Adjusted Price-to-FCF of today is 15.05.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Mega Lifesciences PCL was 54.80. The lowest was 14.79. And the median was 30.77.


Mega Lifesciences PCL Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Mega Lifesciences PCL's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Cyclically Adjusted FCF per Share Chart

Mega Lifesciences PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.06 1.21 1.39 1.62

Mega Lifesciences PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 1.69 1.63 1.62 1.80

Competitive Comparison of Mega Lifesciences PCL's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Lifesciences PCL's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's Cyclically Adjusted Price-to-FCF falls into.


;
;

Mega Lifesciences PCL Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mega Lifesciences PCL's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.147/134.9266*134.9266
=0.147

Current CPI (Mar. 2025) = 134.9266.

Mega Lifesciences PCL Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.105 100.684 0.141
201509 0.127 100.392 0.171
201512 0.250 99.792 0.338
201603 0.232 100.470 0.312
201606 0.073 101.688 0.097
201609 0.437 101.861 0.579
201612 0.366 101.863 0.485
201703 0.203 102.862 0.266
201706 0.136 103.349 0.178
201709 0.203 104.136 0.263
201712 0.264 104.011 0.342
201803 0.374 105.290 0.479
201806 -0.185 106.317 -0.235
201809 0.041 106.507 0.052
201812 -0.048 105.998 -0.061
201903 0.009 107.251 0.011
201906 0.314 108.070 0.392
201909 0.263 108.329 0.328
201912 0.510 108.420 0.635
202003 0.375 108.902 0.465
202006 0.143 108.767 0.177
202009 0.678 109.815 0.833
202012 0.378 109.897 0.464
202103 1.005 111.754 1.213
202106 0.553 114.631 0.651
202109 0.695 115.734 0.810
202112 0.684 117.630 0.785
202203 0.132 121.301 0.147
202206 0.607 125.017 0.655
202209 0.096 125.227 0.103
202212 1.093 125.222 1.178
202303 0.263 127.348 0.279
202306 0.582 128.729 0.610
202309 0.693 129.860 0.720
202312 0.331 129.419 0.345
202403 0.589 131.776 0.603
202406 1.141 132.554 1.161
202409 -0.114 133.029 -0.116
202412 0.848 133.157 0.859
202503 0.147 134.927 0.147

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Mega Lifesciences PCL  (BKK:MEGA-R) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Mega Lifesciences PCL's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=27.08483/1.80
=15.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Mega Lifesciences PCL was 54.80. The lowest was 14.79. And the median was 30.77.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Mega Lifesciences PCL Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL Business Description

Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines